Dendritic Cells May Hold Key for New Lupus Immunotherapy, Study Reports

Re-engineering a class of immune cells called dendritic cells (DCs) toward self-tolerance for many of the antigens underlying systemic lupus erythematosus (SLE) may be a potential therapeutic approach to treat lupus patients and other autoimmune diseases, according to a recent study. Findings from the study, “Autologous tolerogenic dendritic…

Lupus Researchers Reveal Potential New Approach to Controlling Inflammation, and Tissue Damage

Researchers from St. Jude Children’s Research Hospital in Memphis, Tennessee, in collaboration with several other institutions, published findings from a lupus study in which they discovered a new approach to controlling the inflammation and tissue damage that is a hallmark of the chronic autoimmune disorder. The study, “Noncanonical autophagy…